Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyCyclophosphamideTreatment OutcomeAntineoplastic AgentsBone Marrow TransplantationTransplantation, HomologousLymphoma, Non-HodgkinSalvage TherapyTransplantation ConditioningLiver TransplantationChemotherapy, AdjuvantStem Cell TransplantationMultiple MyelomaMelphalanKidney TransplantationHematopoietic Stem Cell MobilizationGraft SurvivalBlood Transfusion, AutologousDisease-Free SurvivalCarmustineEtoposideCell TransplantationSurvival AnalysisRecurrenceBone Marrow PurgingAntigens, CD34Granulocyte Colony-Stimulating FactorHeart TransplantationSurvival RateWhole-Body IrradiationDose-Response Relationship, DrugLeukapheresisHodgkin DiseaseTime FactorsRemission InductionLung TransplantationHematopoietic Stem CellsCytarabineDoxorubicinGraft vs Host DiseaseFollow-Up StudiesPrognosisBusulfanRetrospective StudiesHematologic NeoplasmsOrgan TransplantationImmunosuppressive AgentsGraft RejectionBone MarrowAntineoplastic Agents, AlkylatingFeasibility StudiesCisplatinMyeloablative AgonistsTissue DonorsLymphomaIslets of Langerhans TransplantationPancreas TransplantationTransplantation ImmunologyThalidomideGraft vs Tumor EffectProspective StudiesTransplantationLeukemia, Myeloid, AcuteNeoplasm Recurrence, LocalCells, CulturedNeoplasm, ResidualBlood Component RemovalTransplantation ChimeraVincristineDrug Administration ScheduleAntibodies, MonoclonalDexamethasoneKanamycin KinaseLeukemiaIdarubicinHematopoiesisCell SeparationTransplantation, IsogeneicGenetic TherapyAntibodies, Monoclonal, Murine-DerivedBlood Cell CountBone Marrow CellsPrednisoneColony-Forming Units AssayMyelodysplastic SyndromesBreast NeoplasmsStem CellsCord Blood Stem Cell TransplantationTransplantation, HeterotopicNeoplasmsFlow CytometryLiving DonorsImmunosuppressionImmunomagnetic SeparationCell Culture TechniquesT-Lymphocytes